Evidence map›Paper›PMID 34957697›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

FasL

Zhi-Guo Shan, Yong-Liang Zhao, Jin-Yu Zhang, Zong-Bao Yan, Ting-Ting Wang, Fang-Yuan Mao, Yong-Sheng Teng, Liu-Sheng Peng, Wan-Yan Chen, Pan Wang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Target neutrophil heterogeneity and plasticity in cancer.Journal of hematology & oncology · 2025
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Myeloid cells meet CD8Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Zhi-Guo ShanDepartment of General Surgery and Center of Minimal Invasive Gastrointestinal Surgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.
Yong-Liang ZhaoDepartment of General Surgery and Center of Minimal Invasive Gastrointestinal Surgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.
Jin-Yu ZhangNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.
Zong-Bao YanDepartment of General Surgery and Center of Minimal Invasive Gastrointestinal Surgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.
Ting-Ting WangChongqing Key Research Laboratory for Drug Metabolism, Department of Pharmacology, Chongqing Medical University, Chongqing, 400016, China.
Fang-Yuan MaoNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.
Yong-Sheng TengNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.
Liu-Sheng PengNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.
Wan-Yan ChenNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.
Pan WangNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.
Ping ChengNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.
Wen-Qing TianDepartment of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Jun ChenDepartment of General Surgery and Center of Minimal Invasive Gastrointestinal Surgery, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.
Weisan ChenLa Trobe Institute of Molecular Science, La Trobe University, Bundoora, Victoria, 3085, Australia.
Yuan ZhuangNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy and Laboratory Medicine, Third Military Medical University, Chongqing, 400038, China.ORCID 0000-0001-7825-0032
Army Medical University · CNChongqing Medical University · CNJiangsu University · CNThe Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

Chongqing Natural Science Fund for Distinguished Young Scholars cstc2019jcyjjqX0003Innovation research group in Colleges and Universities Program of Chongqing Municipal Education Commission CXQT20012National Key Research and Development Program of China 2016YFC1302200National Natural Science Foundation of China 81670510National Natural Science Foundation of China 81870394National Natural Science Foundation of China 81872016National Natural Science Foundation of China 81902922National Natural Science Foundation of China 82003039National Natural Science Foundation of China 82070578Science Innovation Capacity Promotion Project of Army Medical University 2019XQY03
6 · The paper itself

Abstract

Neutrophils constitute abundant cellular components in human gastric cancer (GC) tissues, but their protumorigenic subset in pathogenesis of GC progression is unclear. Here, it is found that patients with GC show significantly higher neutrophil infiltration in tumors that is regulated by CXCL12-CXCR4 chemotaxis. These tumor-infiltrating neutrophils express high level immunosuppressive molecules FasL and PD-L2, and this FasL

Indexed as

NeutrophilsStomach NeoplasmsCD8-Positive T-LymphocytesDisease ProgressionHumansNeutrophil InfiltrationFasLgastric cancerneutrophilsPD-L2

Identifiers

PMID34957697
PMCPMC8844550
OpenAlexW4200563926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.